01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $1.06B
1 older move runs past ±100% (largest +133.0%); point at, tap or drag across the bars to read one.
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $1.06B | +30.8% | 10-K | |
| FY2024 | $808.1M | +4.6% | 10-K | |
| FY2023 | $772.9M | +96.1% | 10-K | |
| FY2022 | $394.1M | −38.0% | 10-K | |
| FY2021 | $636.0M | +17.5% | 10-K | |
| FY2020 | $541.1M | +77.9% | 10-K | |
| FY2019 | $304.2M | +7.0% | 10-K | |
| FY2018 | $284.3M | −4.9% | 10-K | |
| FY2017 | $298.9M | +9.0% | 10-K | |
| FY2016 | $274.2M | +97.4% | 10-K | |
| FY2015 | $138.9M | −20.8% | 10-K | |
| FY2014 | $175.3M | +4.1% | 10-K | |
| FY2013 | $168.4M | +2.2% | 10-K | |
| FY2012 | $164.8M | −2.0% | 10-K | |
| FY2011 | $168.2M | +20.2% | 10-K | |
| FY2010 | $139.9M | +12.6% | 10-K | |
| FY2009 | $124.3M | +133.0% | 10-K | |
| FY2008 | $53.3M | — | 10-K |
03—Questions
What is IDEXX Laboratories's current free cash flow?
IDEXX Laboratories (IDXX) annual free cash flow for 2025 was $1.06B, a 30.82% increase from 2024. IDEXX Laboratories free cash flow for the quarter ending September 30, 2026 was $420.8M.
What was IDEXX Laboratories's free cash flow in 2024?
IDEXX Laboratories annual free cash flow for 2024 was $808.1M, a 4.55% increase from 2023.
What was IDEXX Laboratories's free cash flow in 2023?
IDEXX Laboratories annual free cash flow for 2023 was $772.9M, a 96.09% increase from 2022.
What is IDEXX Laboratories's 5-year free cash flow CAGR?
IDEXX Laboratories free cash flow grew at a compound annual growth rate (CAGR) of 14.33% from FY2020 to FY2025, going from $541.1M to $1.06B over 5 years.
- Company
- IDEXX Laboratories
- Ticker
- IDXX
- Sector
- Other
- Industry
- In Vitro & In Vivo Diagnostic Substances